購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
BALB/c-hCD3 Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
BALB/c-hCD3 Mouse
製品名
BALB/c-hCD3 Mouse
製品ID
C001326
系統名
BALB/cAnCya-Cd3tm1(hCD3)/Cya
背景情報
BALB/cAnCya
状況
このマウス系統を論文で使用する場合は、「BALB/c-hCD3 Mouse(カタログ番号C001326)はサイアジェンから購入しました。」と引用してください。
Tumor Target Humanized Mouse Models
Immune Target Humanized Mouse Models
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
Tumor Target Humanized Mouse Models
Immune Target Humanized Mouse Models
基本情報
検証 Data
関連リソース
基本情報
系統詳細
Cluster of differentiation 3 (CD3) is a multimeric protein complex that is essential for T cell activation and antigen recognition. It consists of five different polypeptide chains (γ, δ, ε, ζ, and η) that are noncovalently associated with the T cell receptor (TCR). The TCR is responsible for recognizing antigens presented by antigen-presenting cells (APCs), while CD3 transduces the activation signal into the T cell and activates helper T-cells and cytotoxic T-cells [1-2]. The CD3-TCR complex is expressed on the surface of all mature T cells, and its assembly is required for T cell development and function. CD3 plays a crucial role in stabilizing the TCR and facilitating its interaction with antigens. It also recruits signaling molecules to the TCR, which initiates a cascade of events that leads to T cell activation. CD3 is a highly specific T cell marker, and its expression is increased upon T cell activation. This makes it a valuable tool for identifying and characterizing T cells in tissues and blood samples. CD3 staining is also used to diagnose T-cell lymphomas and leukemias. Due to its essential role in T cell activation, CD3 is a promising target for immunosuppressive therapy. Several anti-CD3 monoclonal antibodies have been developed and are being tested in clinical trials for the treatment of autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis [3].
The BALB/c-hCD3 mice are a CD3 humanized model obtained by replacing the mouse CD3 coding gene with the human CD3 gene using embryonic stem (ES) cell targeting technology. This model can be used to study T cell activation and antigen recognition mechanisms and for the development of CD3-targeted drugs in immunosuppressive therapies for autoimmune diseases.
参考文献
Dong D, Zheng L, Lin J, Zhang B, Zhu Y, Li N, Xie S, Wang Y, Gao N, Huang Z. Structural basis of assembly of the human T cell receptor-CD3 complex. Nature. 2019 Sep;573(7775):546-552.
Dykhuizen M, Ceman J, Mitchen J, Zayas M, MacDougall A, Helgeland J, Rakasz E, Pauza CD. Importance of the CD3 marker for evaluating changes in rhesus macaque CD4/CD8 T-cell ratios. Cytometry. 2000 May 1;40(1):69-75.
Bolt S, Routledge E, Lloyd I, Chatenoud L, Pope H, Gorman SD, Clark M, Waldmann H. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol. 1993 Feb;23(2):403-11.
系統作製戦略
The mouse Cd3e, Cd3d, and Cd3g genes which encode the three components of the CD3 complex, Cd3ε, Cd3δ, and Cd3γ, were replaced by the corresponding human homologous genes.

Figure 1. Diagram of the gene editing strategy for the generation of BALB/c-hCD3 mice.
適用分野
Research on the immune system;
T cell activation and antigen recognition studies;
Research on immunosuppressive therapy for autoimmune diseases;
Development and evaluation of CD3-targeted drugs.
検証 Data
1. Detection of human and murine CD3 expression in CD45+ cells
Human CD3E+ cells were detected in the peripheral blood, thymus, and spleen of homozygous BALB/c-hCD3 mice, while mouse CD3E expression was almost absent. In wild-type mice (WT), only mouse CD3E expression was observed.

Figure 2. Flow cytometry analysis of the expression of human CD3 (hCD3) and mouse CD3 (mCD3).
2. Assessment of cell subset composition in CD45+CD3+ T cells
The proportions of CD3+ T cells and their subsets, CD4+ and CD8+ T cells, in the peripheral blood (PB) and spleen of homozygous BALB/c-hCD3 and wild-type mice were indistinguishable.

Figure 3. Proportion of T cells and their subsets (CD4+ cells and CD8+ cells).
3. Ex Vivo Tumor Killing Effect of PBMCs
Isolated PBMCs from mice were incubated with human multiple myeloma cells (MM1R) for 48 hours to assess their tumor-killing efficacy. The results indicate that BALB/c-hCD3 mouse-derived PBMCs exhibit similar cytotoxic effects against human tumor cells as hPBMCs, while PBMCs from wild-type mice show weaker tumor-killing activity. Additionally, internal data suggests that BALB/c-hCD3 mouse PBMCs outperform similar models in the market (data not shown).
Effector cells (E): PBMC; Target cells (T): MM1R; E:T=1 : 1=2*104 : 2*104; Time: 48h; Antibody: 1nM BiTE.

Figure 4. In vitro cytotoxicity comparison between peripheral blood mononuclear cells (PBMCs) from wild-type mice (BALB/c), PBMCs from BALB/c-hCD3 mice (BALB/c-hCD3), and human PBMCs (hPBMCs).
関連リソース
お問い合わせ
ご不明な点やご質問などございましたら、お気軽にお問い合わせください。担当スタッフがサポートさせていただきます。下記のフォームにご記入いただければ、1〜2営業日以内に折り返しご連絡いたします。
Related Product
All Related ProductsResources
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
